People | September 16, 2025
GAIASO appoints Dr. Tracey Brown as CEO
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
The company is bringing precision therapies for gynaecological cancers
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
Adjusted Profit After Tax (PAT) for the year ended March 31, 2025 was at Rs. 1,389.4 crore
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
Trastuzumab specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein
Subscribe To Our Newsletter & Stay Updated
